(Q48540572)

12 February 2018

title

Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide. (English)

1 reference

12 February 2018

1 reference

1 reference

Carlos Morgan

1

1 reference

12 February 2018

Manuel P Bugueño

series ordinal

2

1 reference

12 February 2018

Jorge Garrido

series ordinal

3

1 reference

12 February 2018

Nibaldo C Inestrosa

series ordinal

4

1 reference

12 February 2018

publication date

1 July 2002

1 reference

12 February 2018

number of pages

12

1 reference

inferred from page(s)

published in

Peptides

1 reference

12 February 2018

volume

23

1 reference

12 February 2018

page(s)

1229-1240

1 reference

12 February 2018

issue

7

1 reference

12 February 2018

Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Rat hippocampal neurons in dispersed cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Growth of a rat neuroblastoma cell line in serum-free supplemented medium

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin blocks the assembly of wild-type Aβ and the Dutch variant peptide into Alzheimer's fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin inhibits amyloid-beta-peptide fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Mechanisms underlying neuronal death induced by chromogranin A-activated microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Chromogranin A induces a neurotoxic phenotype in brain microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Aggregation and disaggregation of senile plaques in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin 1 attenuates beta-amyloid peptide Abeta(1-40) neurotoxicity of cultured fetal rat cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

pH-dependent structural transitions of Alzheimer amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Generation of auto-antibodies towards Alzheimer's disease vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Immunomodulation of the human prion peptide 106-126 aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Observation of metastable Abeta amyloid protofibrils by atomic force microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminins in the adult and aged brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

The environmental dependency of protein folding best explains prion and amyloid diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

A beta amyloidogenesis: unique, or variation on a systemic theme?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Entactin-induced inhibition of human amyloid beta-protein fibril formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

The inhibitory effect of laminin 1 and synthetic peptides deduced from the sequence in the laminin alpha1 chain on Abeta40 fibril formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin inhibits Abeta42 fibril formation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin inhibits both Abeta40 and Abeta42 fibril formation but does not affect Abeta40 or Abeta42-induced cytotoxicity in PC12 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Laminin degradation by plasmin regulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Electron microscopy of prefibrillar structures and amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Shattuck lecture--neurodegenerative diseases and prions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Solvent effects on self-assembly of beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

High-resolution electron microscopic analysis of the amyloid fibril

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

In vivo reversal of amyloid-beta lesions in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Prions: disease propagation and disease therapy by conformational transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Controlling amyloid beta-peptide fibril formation with protease-stable ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Arrest of beta-amyloid fibril formation by a pentapeptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

1 reference

7 January 2021

Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

Inhibition of beta-amyloid cytotoxicity by midkine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900058-X

7 January 2021

10.1016/S0196-9781(02)00058-X

Identifiers

DOI

1 reference

12 February 2018

release_4wkpud3lj5a3bbus5r3wdk6bvq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4wkpud3lj5a3bbus5r3wdk6bvq

24 November 2022

mapped directly with Wikidata item

PubMed ID

12128080

1 reference

12 February 2018